Overview

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Fluvastatin